Last reviewed · How we verify
Port-sites infiltration:Bupivacaine0.25%
Port-sites infiltration:Bupivacaine0.25% is a Local anesthetic Small molecule drug developed by Hospital General Universitario Elche. It is currently in Phase 3 development for Postoperative pain management, Regional anesthesia. Also known as: Port-sites infiltration with bupivacaine.
Bupivacaine blocks sodium channels in nerve fibers, preventing depolarization and relieving pain.
Bupivacaine 0.25% port-sites infiltration is used for postoperative analgesia in laparoscopic sleeve gastrectomy. It has completed a Phase 3 trial and shows promise in reducing pain without significant safety concerns.
At a glance
| Generic name | Port-sites infiltration:Bupivacaine0.25% |
|---|---|
| Also known as | Port-sites infiltration with bupivacaine |
| Sponsor | Hospital General Universitario Elche |
| Drug class | Local anesthetic |
| Target | Voltage-gated sodium channels |
| Modality | Small molecule |
| Therapeutic area | Anesthesiology |
| Phase | Phase 3 |
Mechanism of action
Bupivacaine acts as a local anesthetic by inhibiting the influx of sodium ions through voltage-gated sodium channels, which are essential for the initiation and propagation of nerve impulses. This blockade of sodium channels prevents the depolarization of nerve fibers, resulting in a loss of sensation and pain relief.
Approved indications
- Postoperative pain management
- Regional anesthesia
Common side effects
- Central nervous system toxicity
- Cardiovascular toxicity
- Nausea and vomiting
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Port-sites infiltration:Bupivacaine0.25% CI brief — competitive landscape report
- Port-sites infiltration:Bupivacaine0.25% updates RSS · CI watch RSS
- Hospital General Universitario Elche portfolio CI
Frequently asked questions about Port-sites infiltration:Bupivacaine0.25%
What is Port-sites infiltration:Bupivacaine0.25%?
How does Port-sites infiltration:Bupivacaine0.25% work?
What is Port-sites infiltration:Bupivacaine0.25% used for?
Who makes Port-sites infiltration:Bupivacaine0.25%?
Is Port-sites infiltration:Bupivacaine0.25% also known as anything else?
What drug class is Port-sites infiltration:Bupivacaine0.25% in?
What development phase is Port-sites infiltration:Bupivacaine0.25% in?
What are the side effects of Port-sites infiltration:Bupivacaine0.25%?
What does Port-sites infiltration:Bupivacaine0.25% target?
Related
- Drug class: All Local anesthetic drugs
- Target: All drugs targeting Voltage-gated sodium channels
- Manufacturer: Hospital General Universitario Elche — full pipeline
- Therapeutic area: All drugs in Anesthesiology
- Indication: Drugs for Postoperative pain management
- Indication: Drugs for Regional anesthesia
- Also known as: Port-sites infiltration with bupivacaine
- Compare: Port-sites infiltration:Bupivacaine0.25% vs similar drugs
- Pricing: Port-sites infiltration:Bupivacaine0.25% cost, discount & access